文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[异常血脂谱:何时针对遗传原因进行进一步研究?]

[An abnormal lipid profile: when to perform additional research for a genetic cause?].

作者信息

Heidemann Britt E, Prinssen Monique, Marais A D, Visseren Frank L J, Koopal Charlotte

机构信息

Universitair Medisch Centrum Utrecht, afd. Vasculaire Geneeskunde, Utrecht.

Huisartsenpraktijk Oog in Al, Utrecht.

出版信息

Ned Tijdschr Geneeskd. 2022 Nov 8;166:D6532.


DOI:
PMID:36633039
Abstract

Abnormalities in the lipid profile are common, but it is often not easy to determine their cause. After exclusion of secondary causes, a primary (genetic) cause of dyslipidaemia should be considered. The most common monogenic dyslipidaemia is familial hypercholesterolemia (FH), but there are other clinically relevant genetic dyslipidaemias, including familial dysbetalipoproteinaemia (FD), monogenic chylomicronaemia and hypoalphalipoproteinemia. It is important to make a genetic diagnosis because it may influence the prognosis of the patient, for determining appropriate treatment goals and because it is relevant for family members. This clinical viewpoint explains the diagnostic process of genetic dyslipidaemias using two cases.

摘要

血脂异常很常见,但往往难以确定其病因。排除继发原因后,应考虑血脂异常的原发性(遗传)病因。最常见的单基因血脂异常是家族性高胆固醇血症(FH),但还有其他临床相关的遗传性血脂异常,包括家族性异常β脂蛋白血症(FD)、单基因乳糜微粒血症和低α脂蛋白血症。进行基因诊断很重要,因为它可能影响患者的预后、确定合适的治疗目标,并且与家庭成员相关。这一临床观点通过两个病例解释了遗传性血脂异常的诊断过程。

相似文献

[1]
[An abnormal lipid profile: when to perform additional research for a genetic cause?].

Ned Tijdschr Geneeskd. 2022-11-8

[2]
The role of genetic testing in dyslipidaemia.

Pathology. 2018-12-14

[3]
The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disorders.

Best Pract Res Clin Endocrinol Metab. 2023-5

[4]
The brave new world of genetic testing in the management of the dyslipidaemias.

Curr Opin Cardiol. 2020-5

[5]
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.

Dan Med Bull. 2002-11

[6]
Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.

J Am Coll Cardiol. 2019-7-30

[7]
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.

J Am Heart Assoc. 2021-5-4

[8]
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].

Vnitr Lek. 2016

[9]
Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.

Ont Health Technol Assess Ser. 2022

[10]
Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.

Atherosclerosis. 2017-5-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索